IMPROving MYelin imaging in patients with relapsing-remitting multiple sclerosis (IMPROMYMS study): protocol for a prospective longitudinal study
Year: 2026
Type: article
Study design: Study Protocol
Abstract: INTRODUCTION: It is increasingly recognized that patients with relapsing-remitting multiple sclerosis (RRMS) may experience disability progression in the absence of clinical relapses and new lesions, a phenomenon known as progression independent of relapse- and magnetic resonance imaging (MRI) activity (PIRMA). The biological basis of this type of progression remains poorly understood. Demyelination is the central pathological hallmark of RRMS. Conventional clinical MRI protocols focus primarily on detecting focal lesions. However, advanced imaging techniques that quantify myelin content can provide additional insights beyond visible lesions, helping to better understand the mechanisms that drive clinical deterioration. OBJECTIVE: Therefore, this study named IMPROving MYelin imaging in patients with relapsing-remitting Multiple Sclerosis (IMPROMYMS study) aims to apply myelin imaging techniques to study clinically defined disease progression in patients with RRMS, by assessing myelin content and comparing it to patients with RRMS without progression of the disease. METHODS: In total, 97 patients with RRMS will be included and followed for 2.5 years. Participants will undergo MRI scanning at baseline and after 2 years and have regular clinical follow-up visits. Besides conventional MRI, advanced imaging sequences will be scanned, including gradient spin echo (GRASE), multi-echo gradient echo (ME-GRE), diffusion and functional MRI. Additionally, blood samples will be collected longitudinally to assess circulating biomarkers of neuroaxonal damage and astrocytic activation. Participants can also use the smartphone symptom-monitoring app MS Sherpa to enable more frequent monitoring of functional changes in daily life. In addition, 30 healthy controls will be scanned once as a reference group. In this study, we expect to find radiological prognostic markers of an increased risk of developing PIRMA, so that disease management strategies can be altered accordingly.
Source: Neuroradiology
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,790
Funders: Health~Holland, Hersenstichting
Award: G541909123
OpenAlex ID: W7233965926
